公司资料
CytoSorbents 股价、新闻与催化剂
- 股票代码:
- CTSO
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
5.35 USD (+0.56%)
收盘价
最后更新: 2026年10月21日
30.1M USD
市值
股价为何变动
截至 2026年10月21日，CTSO 上涨 0.56%，收于 $5.35。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
CytoSorbents is a medical technology company focused on blood purification and extracorporeal filtration systems. Its business is centered on critical-care and device-based purification rather than biotech development.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, CytoSorbents sits in medical devices and critical-care technology.
商业模式特征
The company depends on clinical adoption, hospital procurement, and the expansion of its blood-purification platform.
生物医药行业定位
CytoSorbents is a niche medtech name whose valuation is tied to adoption and clinical utility.
未来催化剂
- CytoSorbents’ catalysts are CytoSorb adoption, international reimbursement, and any update that shows hospital usage is stabilizing. The company needs to keep proving that the therapy can become a recurring part of critical-care workflow.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。